- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Vaishali Pharma Limited has announced a board meeting outcome where it was decided to execute a Share Subscription Agreement to acquire a 51.02% stake in Kesar Pharma Limited by subscribing to 35,89,201 equity shares at a price of ₹56.89 per share. The total investment amounts to ₹20.42 crore, comprising ₹8.17 crore in cash and the remainder through the issuance of new equity shares. This strategic acquisition aims to enhance Vaishali Pharma's market presence and expand its product offerings in the pharmaceutical sector, with Kesar Pharma expected to become a subsidiary.